This Plain Language Summary of Publication article (PLSP) from Current Medical Research and Opinion describes a meta-analysis examining empagliflozin’s safety profile by analyzing side effects across four large clinical studies involving 20,933 participants with type 2 diabetes, heart failure, or chronic kidney disease. The research compared adverse events between participants taking empagliflozin versus those taking placebo.

Visit the site using this link to read the article

This PLSP is based on an article called ‘Safety of Empagliflozin: An Individual Participant-Level Data Meta-Analysis from Four Large Trials’ and was published in Advances in Therapy.

Visit Springer Nature Link using the link to read the original article.